Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold

The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.

...

These 3 stocks are troubled but I'm not ready to give up

4 weeks ago

Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start

4 weeks ago

NY Gov. Hochul signs bill to protect abortion providers sending pills into states with bans

3 weeks ago

How New York City's sky-high cost of living stacks up to London

3 weeks ago

Eli Lilly experimental obesity drug helped patients lose up to 24% of their weight, study says

3 weeks ago